Luís Costa, MD, PhD, is Professor of Medicine at the Lisbon School of Medicine, University of Lisbon, Portugal where he coordinates the teaching of oncobiology, which is a new learning unit that aims to teach an understanding of clinical oncology through molecular medicine. He has been head of the Oncology Department at Hospital de Santa Maria in Lisbon since 2005, and was appointed as the director of the Clinical Research Centre at the Lisbon Academic Medical Centre in 2015. Since 2007, Prof. Costa has been the head of the Clinical and Translational Oncology Research Unit at Instituto de Medicina Molecular.
Prof. Costa has been involved in multiple clinical trials in breast cancer and other solid tumours, and his research interests have long centred on the area of bone metastases. In recent years, his research has focused on understanding the molecular mechanisms of tumour progression at metastatic sites using bone metastases as a paradigm.
Prof. Costa also acts as an expert for grant reviews at the European Research Council, Cancer Research UK, the French National Cancer Institute, and the Netherlands Cancer Institute. He is Academic Editor for Plos One, the Journal of Bone Oncology and Annals of Medicine and has published more than 150 peer-reviewed articles and other publications.
